Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

SELL
$463.67 - $597.16 $275,883 - $355,310
-595 Reduced 59.38%
407 $201,000
Q1 2022

May 12, 2022

SELL
$524.57 - $735.42 $6.45 Million - $9.04 Million
-12,290 Reduced 92.46%
1,002 $564,000
Q4 2021

Jan 25, 2022

BUY
$708.84 - $794.68 $157,362 - $176,418
222 Added 1.7%
13,292 $10 Million
Q3 2021

Nov 04, 2021

BUY
$657.71 - $825.77 $112,468 - $141,206
171 Added 1.33%
13,070 $9.75 Million
Q2 2021

Aug 09, 2021

SELL
$576.64 - $649.04 $84,189 - $94,759
-146 Reduced 1.12%
12,899 $8.31 Million
Q1 2021

May 14, 2021

SELL
$547.01 - $662.35 $1.56 Million - $1.88 Million
-2,845 Reduced 17.9%
13,045 $7.45 Million
Q4 2020

Feb 09, 2021

BUY
$510.68 - $643.45 $67,409 - $84,935
132 Added 0.84%
15,890 $9.26 Million
Q3 2020

Nov 05, 2020

BUY
$454.43 - $535.6 $5.72 Million - $6.75 Million
12,598 Added 398.67%
15,758 $8.12 Million
Q2 2020

Jul 30, 2020

BUY
$334.87 - $493.06 $54,583 - $80,368
163 Added 5.44%
3,160 $1.43 Million
Q1 2020

May 08, 2020

BUY
$320.01 - $409.07 $79,042 - $101,040
247 Added 8.98%
2,997 $1.05 Million
Q4 2019

Feb 06, 2020

BUY
$319.73 - $374.2 $879,257 - $1.03 Million
2,750 New
2,750 $1.02 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.38B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Hancock Whitney Corp Portfolio

Follow Hancock Whitney Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

News

Stay updated on Hancock Whitney Corp with notifications on news.